Closing the gaps in TB detection — considerations for policy makers
Decentralised molecular testing for TB could reduce missed diagnoses and losses to follow-up in high-burden settings.
A
study
published in The Lancet Global Health reported on the
cost and cost-effectiveness analysis of decentralised molecular
testing for TB in Uganda.
An accompanying comment can
be accessed
here.
